Form 4: Definitive Healthcare CFO Granted Significant RSUs

Definitive Healthcare Corp.'s CFO, Casey Heller, was granted 195,313 restricted stock units, vesting over time subject to continued service.

Summary

• Casey Heller, Chief Financial Officer of Definitive Healthcare Corp. (DH), acquired 195,313 shares of Class A Common Stock.
• The acquisition occurred on January 5, 2026, and was in the form of Restricted Stock Units (RSUs) at a price of $0 per share.
• These RSUs represent a contingent right to receive one share of Class A Common Stock for each unit.
• The vesting schedule for these RSUs is 50% on January 1, 2027, followed by equal quarterly installments over the subsequent 12 months.
• Vesting is contingent upon Ms. Heller's continued service with Definitive Healthcare Corp. through each vesting date.
• Following this transaction, Ms. Heller beneficially owns 1,275,490 shares of Class A Common Stock directly.

Sentiment

Score: 6

Explanation: Slightly positive, as the RSU grant aligns executive incentives with shareholder interests and promotes long-term retention, which are generally viewed favorably.

Positives

• The grant of Restricted Stock Units (RSUs) to the Chief Financial Officer aligns management's long-term interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• The multi-year vesting schedule encourages executive retention, ensuring continuity in key leadership roles.

Negatives

• The issuance of new shares upon vesting of RSUs will result in a minor dilutive effect for existing shareholders, though this is a standard component of executive compensation plans.

Risks

• The value of the RSU grant to the reporting person is subject to the future market price fluctuations of Definitive Healthcare Corp.'s Class A Common Stock.
• The RSUs are subject to forfeiture if the reporting person's service with the Issuer terminates before the vesting dates.

Future Outlook

The RSU grant with its multi-year vesting schedule indicates an expectation of continued service from the Chief Financial Officer and aims to align her long-term financial incentives with the company's future performance and shareholder value creation.

Industry Context

Executive compensation, particularly through equity grants like RSUs, is a standard practice across the technology and healthcare information industries. Such grants are designed to attract, retain, and motivate key executives by linking their personal wealth to the company's long-term success and stock performance.

Comparison to Industry Standards

• The structure of this RSU grant, including the multi-year vesting schedule and the use of equity as a significant component of executive compensation, is consistent with common practices observed among publicly traded companies in the healthcare technology and data analytics sectors.
• While specific grant sizes vary based on company size, executive role, and performance, the general mechanism of using RSUs to foster long-term alignment and retention is a global benchmark in executive compensation.

Related Party Transactions

• The RSU grant to Casey Heller, the Chief Financial Officer, constitutes a related party transaction as it involves compensation from the company to a key executive. This is a standard form of executive compensation.

Stakeholder Impact

• Shareholders: Potential minor dilution upon vesting of RSUs, but also benefit from increased alignment of executive interests with long-term company performance.
• Employees: May signal stability in executive leadership and a commitment to long-term growth.
• Management: Provides a significant long-term incentive tied to the company's stock performance and continued service.

Next Steps

• The granted RSUs will vest in two main phases: 50% on January 1, 2027, and the remaining 50% in equal quarterly installments over the subsequent 12 months, subject to continued service.

Key Dates

Keywords

Definitive Healthcare, DH, Casey Heller, CFO, Restricted Stock Units, RSUs, Insider Transaction, Executive Compensation, Stock Grant, Beneficial Ownership